Immix Biopharma, Inc. Liquidation Value
IMMX
Other
Cash & Equivalents
$93.93M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $93.93M
Total Obligations: -$11.18M
$82.75M
Per share: $1.56
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $93.93M
AR: $0
Total Obligations: -$11.18M
$82.75M
Per share: $1.56
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $93.93M
AR: $0
Inventory: $0
Total Obligations: -$11.18M
$82.75M
Per share: $1.56
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $82.75M | $1.56 |
| Liquid Liquidation Value | $82.75M | $1.56 |
| Operating Liquidation Value | $82.75M | $1.56 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $93.93M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $10.11M |
| Long-term Debt | N/A |
| Op. Lease Liability | $1.07M |
| Finance Lease | N/A |
| Shares Outstanding | 53.0M |
Explore all 270 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $93.93M | N/A | N/A | $5.44M | $10.11M | N/A | $1.07M | N/A |
| 2025-09-30 | $15.95M | N/A | N/A | $7.05M | $10.85M | N/A | $1.11M | N/A |
| 2025-06-30 | $11.64M | N/A | N/A | $6.61M | $10.01M | N/A | $1.04M | N/A |
| 2025-03-31 | $15.92M | N/A | N/A | $5.74M | $9.31M | N/A | $1.06M | N/A |
| 2024-12-31 | $17.68M | N/A | N/A | $5.39M | $8.69M | N/A | $1.07M | N/A |
| 2024-09-30 | $19.69M | N/A | N/A | $3.29M | $6.56M | N/A | $1.09M | N/A |
| 2024-06-30 | $23.98M | N/A | N/A | $2.35M | $3.90M | N/A | $1.09M | N/A |
| 2024-03-31 | $29.32M | N/A | N/A | $3.51M | $5.66M | N/A | $1.09M | N/A |
▼ Community Notes